Verition Fund Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,587
Closed -$322K 3274
2025
Q4
$322K Sell
13,587
-13,196
-49% -$321K ﹤0.01% 2960
2025
Q3
$667K Sell
26,783
-57,848
-68% -$1.24M ﹤0.01% 2847
2025
Q2
$1.95M Buy
84,631
+64,491
+320% +$1.49M 0.01% 1974
2025
Q1
$452K Sell
20,140
-39,729
-66% -$923K ﹤0.01% 2645
2024
Q4
$1.17M Buy
59,869
+35,536
+146% +$704K ﹤0.01% 1944
2024
Q3
$443K Sell
24,333
-12,606
-34% -$241K ﹤0.01% 2391
2024
Q2
$642K Buy
36,939
+13,077
+55% +$232K ﹤0.01% 1919
2024
Q1
$467K Buy
+23,862
New +$504K ﹤0.01% 2034
2023
Q1
Sell
-9,399
Closed -$213K 2479
2022
Q4
$213K Sell
9,399
-17,861
-66% -$497K ﹤0.01% 1720
2022
Q3
$928K Buy
+27,260
New +$1.01M 0.01% 1454

Other funds holding PRVA

Verition Fund Management's PRVA Position: Q1 2026 in Review

Verition Fund Management sold out of Privia Health (PRVA) in Q1 2026, closing a stake of 13,587 shares — an estimated $322K sold.

Verition Fund Management first reported a position in PRVA in Q3 2022 and held it in 10 quarters. The position peaked at $1.95M in Q2 2025. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • Verition Fund Management reported no remaining Privia Health position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 13,587 Privia Health shares in Q1 2026, an estimated $322K.
  • Verition Fund Management first reported a position in Privia Health in Q3 2022 and held it in 10 quarters.
  • Verition Fund Management's Privia Health position peaked at $1.95M in Q2 2025.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.